Validating novel targets for pharmacological interventions in schizophrenia. (Record no. 18987253)

MARC details
000 -LEADER
fixed length control field 01321 a2200349 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250515175659.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 200908s 0 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 1535-7228
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.1176/appi.ajp.2009.09040522
Source of number or code doi
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Language of cataloging eng
Transcribing agency NLM
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Wroblewska, Barbara
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Date of production, publication, distribution, manufacture, or copyright notice 20090814
245 00 - TITLE STATEMENT
Title Validating novel targets for pharmacological interventions in schizophrenia.
Medium [electronic resource]
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. The American journal of psychiatry
Date of publication, distribution, etc. Jul 2009
300 ## - PHYSICAL DESCRIPTION
Extent 753-6 p.
Other physical details digital
500 ## - GENERAL NOTE
General note Publication Type: Editorial
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Antipsychotic Agents
General subdivision pharmacology
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Benzodiazepines
General subdivision pharmacology
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Drug Therapy
General subdivision methods
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element GTP-Binding Proteins
General subdivision drug effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Humans
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Olanzapine
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Receptors, GABA
General subdivision drug effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Receptors, Glutamate
General subdivision drug effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Receptors, Metabotropic Glutamate
General subdivision drug effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Receptors, N-Methyl-D-Aspartate
General subdivision drug effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Reproducibility of Results
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Schizophrenia
General subdivision drug therapy
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Lewis, David A
773 0# - HOST ITEM ENTRY
Title The American journal of psychiatry
Related parts vol. 166
-- no. 7
-- p. 753-6
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.1176/appi.ajp.2009.09040522">https://doi.org/10.1176/appi.ajp.2009.09040522</a>
Public note Available from publisher's website

No items available.